Brokerages Set Encompass Health Co. (NYSE:EHC) Price Target at $93.29

Encompass Health Co. (NYSE:EHC) has been assigned a consensus rating of “Buy” from the ten research firms that are presently covering the stock, Marketbeat.com reports. Eight investment analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $96.50.

A number of research analysts have recently commented on EHC shares. SVB Leerink initiated coverage on Encompass Health in a research report on Wednesday, July 10th. They set an “outperform” rating and a $100.00 target price for the company. Raymond James restated a “strong-buy” rating and issued a $95.00 target price (up from $85.00) on shares of Encompass Health in a report on Friday, April 26th. Stephens reaffirmed an “overweight” rating and issued a $94.00 price target on shares of Encompass Health in a report on Wednesday, June 5th. Truist Financial boosted their price objective on Encompass Health from $95.00 to $100.00 and gave the stock a “buy” rating in a research note on Monday. Finally, Leerink Partnrs raised Encompass Health to a “strong-buy” rating in a research note on Wednesday, July 10th.

Insiders Place Their Bets

In other news, insider Elissa Joy Charbonneau sold 10,000 shares of the business’s stock in a transaction on Friday, May 24th. The shares were sold at an average price of $85.02, for a total transaction of $850,200.00. Following the completion of the sale, the insider now directly owns 18,594 shares of the company’s stock, valued at $1,580,861.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, EVP John Patrick Darby sold 14,543 shares of the company’s stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $83.94, for a total value of $1,220,739.42. Following the completion of the sale, the executive vice president now owns 84,773 shares of the company’s stock, valued at approximately $7,115,845.62. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Elissa Joy Charbonneau sold 10,000 shares of the company’s stock in a transaction on Friday, May 24th. The stock was sold at an average price of $85.02, for a total value of $850,200.00. Following the sale, the insider now owns 18,594 shares of the company’s stock, valued at approximately $1,580,861.88. The disclosure for this sale can be found here. Insiders have sold a total of 69,519 shares of company stock worth $5,816,091 over the last quarter. Company insiders own 2.10% of the company’s stock.

Hedge Funds Weigh In On Encompass Health

Several institutional investors and hedge funds have recently bought and sold shares of EHC. Legacy Wealth Asset Management LLC boosted its stake in Encompass Health by 1.5% in the 1st quarter. Legacy Wealth Asset Management LLC now owns 8,619 shares of the company’s stock worth $712,000 after purchasing an additional 130 shares in the last quarter. Smith Group Asset Management LLC lifted its stake in shares of Encompass Health by 1.2% during the first quarter. Smith Group Asset Management LLC now owns 12,070 shares of the company’s stock worth $997,000 after buying an additional 140 shares during the period. Benjamin Edwards Inc. grew its holdings in shares of Encompass Health by 3.8% during the fourth quarter. Benjamin Edwards Inc. now owns 3,885 shares of the company’s stock valued at $259,000 after buying an additional 142 shares during the last quarter. Horrell Capital Management Inc. increased its position in shares of Encompass Health by 0.5% in the 1st quarter. Horrell Capital Management Inc. now owns 29,371 shares of the company’s stock valued at $2,425,000 after acquiring an additional 147 shares during the period. Finally, GAMMA Investing LLC raised its stake in Encompass Health by 31.9% in the 1st quarter. GAMMA Investing LLC now owns 616 shares of the company’s stock worth $51,000 after acquiring an additional 149 shares during the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

Encompass Health Price Performance

Shares of NYSE:EHC opened at $85.49 on Tuesday. The firm has a market cap of $8.61 billion, a price-to-earnings ratio of 23.11, a P/E/G ratio of 1.35 and a beta of 0.89. The firm has a fifty day moving average price of $85.32 and a 200 day moving average price of $79.02. Encompass Health has a fifty-two week low of $57.55 and a fifty-two week high of $87.94. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.37 and a current ratio of 1.37.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Wednesday, April 24th. The company reported $1.12 earnings per share for the quarter, beating analysts’ consensus estimates of $0.93 by $0.19. The firm had revenue of $1.32 billion during the quarter, compared to analyst estimates of $1.27 billion. Encompass Health had a return on equity of 18.01% and a net margin of 7.60%. The business’s quarterly revenue was up 13.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.88 earnings per share. As a group, sell-side analysts expect that Encompass Health will post 4.09 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, July 15th. Investors of record on Monday, July 1st were issued a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 0.70%. The ex-dividend date was Monday, July 1st. Encompass Health’s payout ratio is currently 16.22%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.